Global /Australia /Healthcare /Biotechnology /TGH

Terragen Holdings Ltd.

TGH

• ASX: TGH • Delayed

0.0240AUD 0%

0.0169 USD

As of 15 June 2026, Terragen Holdings Ltd. has a market cap of $13.92M USD, ranking #39425 globally and #1206 in Australia. It ranks #3510 in the Healthcare sector, and #685 in the Biotechnology industry.

Global Rank

39425

Country Rank

1206

Sector Rank

3510

Industry Rank

685

Key Stats

Market Cap

$13.92MUSD

19.76M AUD

Enterprise Value

$12.28MUSD

17.43M AUD

Revenue (TTM)

$981.95KUSD

1.39M AUD

EBITDA (TTM)

-$2.72MUSD

-3.87M AUD

Net Income (TTM)

-$2.26MUSD

-3.2M AUD

EBITDA Margin

-277%

Profit Margin

-230%

PS Ratio

14.2

PB Ratio

4.1

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Biotechnology

CEO

Richard Norton open_in_new

Founded

1996

Website

terragen.com.au open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	4.3%	14%	-4%	9.1%	4.3%	-20%	-26%	-92%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	TGH Terragen Holdings Ltd Ordinary Shares ISIN: AU0000062333 Shares Out.: Shares Outstanding: 823.199M¹ Shares Float: 797.998M² TV: TradingView: ASX: TGH SA: Stock Analysis: ASX: TGH YF: Yahoo Finance: TGH.AX GF: Google Finance: ASX: TGH BA: Barron's: TGH MS: Morningstar: XASX: TGH	0.0240 AUD	TV: TradingView: ASX: TGH SA: Stock Analysis: ASX: TGH YF: Yahoo Finance: TGH.AX GF: Google Finance: ASX: TGH BA: Barron's: TGH MS: Morningstar: XASX: TGH

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Terragen Holdings Ltd.

Terragen Holdings Limited engages in the research, development, and commercialization of biological products for the agriculture sector in Australia and New Zealand. The company offers Mylo and Terragen Probiotic for Ruminants, which are animal feed supplement probiotics for cows and calves; and Great Land Plus, a bio-stimulant for plants. Terragen Holdings Limited was incorporated in 1996 and is based in Coolum Beach, Australia.

Similar Companies

Industry: Biotechnology (Australia)

Name	Market Cap (USD) diff.	PE	Country
CSL Ltd. ASX: CSL	$42.46B 60.27B AUD 305K%	29.3	Australia
Telix Pharmaceuticals Ltd. ASX: TLX	$3.58B 5.09B AUD 26K%	-	Australia
Mesoblast Ltd. ASX: MSB	$2.03B 2.88B AUD 14K%	-	Australia
PolyNovo Ltd. ASX: PNV	$491.57M 697.75M AUD 3K%	71.8	Australia
Kazia Therapeutics Ltd. NASDAQ: KZIA	$141.64M 918%	-	Australia
Immutep Ltd. ASX: IMM	$65.41M 92.84M AUD 370%	-	Australia

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 1M%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 1M%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 344K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.92B 68.19T KRW 323K%	35.5	South Korea
Lonza Group AG SIX: LONN	$42.17B 33.71B CHF 303K%	37.2	Switzerland
Celltrion, Inc. KRX: 068270	$28.17B 42.76T KRW 202K%	43.8	South Korea

chevron_leftBack